Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04493853 |
|---|---|
| Brief Title: | Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency (CAPItello-281) |
| First Submitted : | July 9, 2020 |
| First Submitted that Met QC Criteria : | July 27, 2020 |
| First Posted : | July 30, 2020 |
| Last Update Submitted that Met QC Criteria : | April 24, 2024 |
| Last Update Posted : | April 25, 2024 |